PGT104 - A phase II trial of XYOTAX(TM) [paclitaxel poliglumex; Cell Therapeutics], cisplatin and radiation for esophageal and gastric cancer
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Cisplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 13 Nov 2005 New trial record.